v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Current Assets:    
Cash and cash equivalents $ 301,309 $ 459,174
Prepaid expenses 404,808 159,985
Total Current Assets 706,117 619,159
Total Assets 706,117 619,159
Current Liabilities:    
Accounts payable- trade 1,371,309 1,512,090
Accrued expenses 869,681 596,465
Financing liability 240,698
Total Current Liabilities 2,481,688 2,108,555
Total Liabilities 2,481,688 2,108,555
Commitments and contingencies (Note 11)
Stockholders’ Deficit:    
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding as of March 31, 2026 and December 31, 2025
Common stock, $0.0001 par value, 50,000,000 shares authorized, 8,786,229 shares issued and outstanding as of March 31, 2026 and 8,655,829 shares issued and outstanding as of December 31, 2025 879 866
Additional paid-in capital 8,661,447 7,801,539
Accumulated deficit (10,437,897) (9,291,801)
Total Stockholders’ Deficit (1,775,571) (1,489,396)
Total Liabilities and Stockholders’ Deficit $ 706,117 $ 619,159

Source

10-Q PDF XBRL Zip